Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Endo Int'l Plc (ENDP)

Endo Int'l Plc (ENDP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 90,072
  • Shares Outstanding, K 235,114
  • Annual Sales, $ 2,993 M
  • Annual Income, $ -613,250 K
  • 60-Month Beta 1.12
  • Price/Sales 0.03
  • Price/Cash Flow 0.07
  • Price/Book N/A
Trade ENDP with:
  • Price/Earnings ttm 0.12
  • Earnings Per Share ttm 2.95
  • Most Recent Earnings 0.66 on 05/05/22
  • Next Earnings Date 08/04/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 334.48% ( +11.32%)
  • Historical Volatility 296.36%
  • IV Percentile 94%
  • IV Rank 26.98%
  • IV High 1,062.34% on 06/08/22
  • IV Low 65.58% on 03/25/22
  • Put/Call Vol Ratio 0.07
  • Today's Volume 38,225
  • Volume Avg (30-Day) 2,333
  • Put/Call OI Ratio 0.24
  • Today's Open Interest 49,014
  • Open Int (30-Day) 50,328

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Sell
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate -0.15
  • Number of Estimates 3
  • High Estimate -0.13
  • Low Estimate -0.17
  • Prior Year 0.65
  • Growth Rate Est. (year over year) -123.08%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2800 +153.57%
on 06/16/22
0.8200 -13.41%
on 06/28/22
+0.2400 (+51.06%)
since 05/27/22
3-Month
0.2800 +153.57%
on 06/16/22
2.8300 -74.91%
on 04/19/22
-1.7200 (-70.78%)
since 03/28/22
52-Week
0.2800 +153.57%
on 06/16/22
7.0652 -89.95%
on 11/11/21
-4.2400 (-85.66%)
since 06/28/21

Most Recent Stories

More News
Endo (ENDP) Inks Deal for Osteoarthritis Knee Pain Drug

Endo (ENDP) collaborates with Taiwan Liposome to commercialize TLC599, an extended and controlled release liposomal formulated dexamethasone for chronic knee osteoarthritis (OA) pain.

ENDP : 0.7100 (+85.33%)
GERN : 1.5000 (+6.38%)
ALKS : 30.39 (+2.08%)
BOLT : 1.8600 (-4.12%)
Endo Executes Agreement With TLC to Commercialize Phase 3 Orthopedic Product for the Treatment of Osteoarthritis Knee Pain

/CNW/ -- Endo International plc (NASDAQ: ENDP) announced today that its subsidiary Endo Ventures Limited (EVL) has executed an agreement with Taiwan Liposome...

ENDP : 0.7100 (+85.33%)
Endo Executes Agreement With TLC to Commercialize Phase 3 Orthopedic Product for the Treatment of Osteoarthritis Knee Pain

/PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that its subsidiary Endo Ventures Limited (EVL) has executed an agreement with Taiwan...

ENDP : 0.7100 (+85.33%)
TLC Announces TLC599 Agreement with Endo

One of the largest deals seen in Taiwan’s biotech sector...

TLC.AX : 4.430 (-2.42%)
ENDP : 0.7100 (+85.33%)
National Survey of Over 1,500 Men Shows More Than Half Were Unsure of How to Improve Their Mental and Sexual Health; New Partnership Aims to Change That Through Education and Free Virtual Consultations

Endo, Vault Health, the Sexual Medicine Society of North America (SMSNA) and Men's Health Network (MHN) join forces to launch Healthy Now: A Men's Health...

ENDP : 0.7100 (+85.33%)
Endo (ENDP) Crashes 46.54% as it Looks to Restructure Debt

Endo (ENDP) plunges on reports of negotiations with its lenders and senior bondholders about a possible restructuring of more than $8 billion of debt.

ENDP : 0.7100 (+85.33%)
GERN : 1.5000 (+6.38%)
ALKS : 30.39 (+2.08%)
HALO : 45.78 (-2.68%)
Why Shares of Endo International Plummeted 69% on Wednesday

Reports that the specialty pharmaceutical company is looking to restructure debt prompted the drop.

ENDP : 0.7100 (+85.33%)
Buxton Helmsley Issues Letter to Endo International Plc. Shareholders and Creditors, Relating to Corporate Malfeasance and False Statements of Financials

The Buxton Helmsley Group, Inc. (together with certain of its affiliates and clients, “BHG” or “we”), the New York City-based investment advisor to clients with financial interests in Endo International...

ENDP : 0.7100 (+85.33%)
Endo (ENDP) Beats on Q1 Earnings, Guides Weak Q2 Results

Endo (ENDP) tops Q1 earnings and sales estimates. However, Vasostrict faces generic competition and the guidance for Q2 is dismal.

ENDP : 0.7100 (+85.33%)
ALKS : 30.39 (+2.08%)
VRTX : 276.17 (-3.88%)
CLVS : 1.7100 (unch)
Why Endo International Stock Is Cratering Today

The company provided disappointing Q2 guidance.

ENDP : 0.7100 (+85.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Endo International plc is a global specialty pharmaceutical company, which is focused on branded and generic pharmaceuticals. The four reportable business segments are: (1) Branded Pharmaceuticals, (2) Sterile Injectables, (3) Generic Pharmaceuticals and (4) International Pharmaceuticals. The Branded...

See More

Key Turning Points

3rd Resistance Point 1.2401
2nd Resistance Point 1.0301
1st Resistance Point 0.8700
Last Price 0.7100
1st Support Level 0.4999
2nd Support Level 0.2899
3rd Support Level 0.1298

See More

52-Week High 7.0652
Fibonacci 61.8% 4.4733
Fibonacci 50% 3.6726
Fibonacci 38.2% 2.8719
Last Price 0.7100
52-Week Low 0.2800

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar